{"sourcedb":"DevicePMAs@therightstef","sourceid":"P030005_S000","text":"Approval for the contak renewal tr.  The device is indicated s follows:  the contak renewal tr pulse generator is indicated for patients who have moderate to severe heart failure (nyha class iii/iv) including left ventricular dysfunction (ef \u003C= 35%) and qrs duration \u003E= 120 ms and remain symptomatic despite stable, optimal heart failure drug therapy (as defined in the clinical trials section).  The device provides atrial-ventricular tracking modes to help preserve av synchrony, and adaptive-rate pacing for patients who would benefit from adjusted pacing rates concurrent with physical activity.","project":"consensus_PMA_Age_Indications"}